Increased Serum Soluble Interleukin-2 Receptor Associated with Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease - Concepedia

Concepedia

Publication | Open Access

Increased Serum Soluble Interleukin-2 Receptor Associated with Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

DOI Full Paper Access

10

Citations

24

References

2021

Year

Yue Zhang, Lianping Ren, Jinyuan Sun, Fengfeng Han, Xuejun Guo

International Journal of COPD

Abstract

Increased serum sIL-2R concentration correlated with the risk of the adverse outcomes in AECOPD, indicating that it can be a predictive factor contributing to the diagnosis and assessment of adverse outcomes in patients with AECOPD.

References

	Year	Citations
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation Mary E. Charlson, Peter Pompei, Kathy L. Aleš, Journal of Chronic Diseases Prognostic AssessmentLongitudinal StudiesPrognostic ComorbidityRetrospective Cohort StudyPsychiatry	1987	48.8K
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Spencer L James, Degu Abate, Kalkidan Hassen Abate, The Lancet	2018	13.6K
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Theo Vos, Amanuel Alemu Abajobir, Kalkidan Hassen Abate, The Lancet	2017	13.3K
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease James C. Hogg, Fanny Chu, Soraya Utokaparch, New England Journal of Medicine	2004	3.7K
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary Claus Vogelmeier, Gerard J. Criner, Fernando J. Martínez, American Journal of Respiratory and Critical Care Medicine	2017	3.2K
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease John R. Hurst, Jørgen Vestbo, Antonio Anzueto, New England Journal of Medicine	2010	2.9K
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort MeiLan K. Han, P. Miguel Quibrera, Elizabeth E. Carretta, The Lancet Respiratory Medicine	2017	304
The value of blood cytokines and chemokines in assessing COPD Eric Bradford, Sean Jacobson, Jason Varasteh, Respiratory Research	2017	116
Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD Juan Fu, Vanessa M. McDonald, Katherine J. Baines, CHEST Journal AsthmaInflammationInflammatory Lung DiseaseAllergyLung Inflammation	2015	111
Biomarkers in COPD Mario Cazzola, Giuseppe Novelli Pulmonary Pharmacology & Therapeutics Biomarker (Medicine)PathologyBiomarkersPulmonary MedicineMedicine	2010	72

Page 1